7 vs 14 Days of Antibiotics for Bacteremia, Factor XI Inhibition for Atrial Fibrillation, ACEi or ARB Before Elective Surgery, GLP-1 Agonist for HFpEF and Obesity
Last Week in Medicine
00:00
Reassessing Antibiotic Treatments and Anticoagulant Innovations
This chapter explores a clinical trial on a seven-day antibiotic regimen for bacteremia, emphasizing the trial's design and impact on treatment durations. It also discusses new developments in anticoagulants, particularly a trial comparing abilacibab and rivaroxaban for atrial fibrillation management.
Play episode from 18:45
Transcript
